- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 27.9683 ↓ -1.25%
[as on 13 February, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of LIC MF Healthcare Fund-Regular Plan-Growth and its peers as on 13 February, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| LIC MF Healthcare Fund-Regular Plan-Growth | -3.74% | -1.25% | 0.89% | -3.58% | -6.63% | -0.11% | - | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | -0.83% | -1.01% | 1.51% | -0.86% | -3.72% | 2.74% | 24.22% | 15.63% | 20.13% | 12.21% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -1.99% | -0.96% | -0.18% | -0.98% | -1.26% | 9.59% | 13.98% | 11.45% | 13.78% | 14.08% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -1.53% | -1.22% | -0.36% | 1.68% | -1.55% | 7.95% | 21.49% | 20.31% | 20.33% | 17.55% |
| SBI PSU Fund - REGULAR PLAN -Growth | 5.46% | -1.19% | 1.41% | 5.72% | 5.88% | 28.78% | 33.68% | 28.49% | 22.21% | 16.99% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -3.56% | -1.06% | 0.58% | -1.64% | -4.97% | 0.24% | 12.71% | 15.45% | 14.98% | 15.62% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 42.5% | -4.82% |
Discrete returns (monthly)
| Month | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 |
|---|
| Returns | 0.74% | 0.52% | 3.25% | 4.08% | -1.32% | -0.29% | 2% | -0.46% | -1.96% | -6.38% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | -4.16% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 97.11% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
2.90% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.39% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.90% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.35% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 5.34% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 4.92% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 4.74% |
| Neuland Laboratories Ltd. | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 4.54% |
| Piramal Pharma Ltd. | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 4.52% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.07% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.91% |
| Onesource Specialty Pharma Ltd. | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 3.59% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 3.20% |
| Navin Fluorine International Ltd. | NAVINFLUOR (INE048G01026) | Chemicals & Petrochemicals | 3.11% |
| Artemis Medicare Services Ltd. | ARTEMISMED (INE025R01021) | Healthcare Services | 3.08% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.94% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.66% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.59% |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.57% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.33% |
| Dr Agarwal's Health Care Ltd. | AGARWALEYE (INE943P01029) | Healthcare Services | 2.29% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 2.24% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 2.20% |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 2.10% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 2.03% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 1.92% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.86% |
| Vinati Organics Ltd. | VINATIORGA (INE410B01037) | Chemicals & Petrochemicals | 1.65% |
| Linde India Ltd. | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 1.07% |
Portfolio data is as on date 31 October, 2025
NAV history
LIC MF Healthcare Fund-Regular Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 13 February, 2026 | 27.9683 |
| 12 February, 2026 | 28.3212 |
| 11 February, 2026 | 28.3017 |
| 10 February, 2026 | 28.0998 |
| 9 February, 2026 | 28.1554 |
| 6 February, 2026 | 27.722 |
| 5 February, 2026 | 27.6861 |
| 4 February, 2026 | 27.7556 |
| 3 February, 2026 | 27.7785 |
| 2 February, 2026 | 27.2021 |
| 30 January, 2026 | 27.3854 |
| 29 January, 2026 | 26.9621 |
| 28 January, 2026 | 27.1265 |
| 27 January, 2026 | 27.0719 |
| 23 January, 2026 | 27.3198 |
| 22 January, 2026 | 27.7548 |
| 21 January, 2026 | 27.5808 |
| 20 January, 2026 | 27.7925 |
| 19 January, 2026 | 28.4795 |
| 16 January, 2026 | 28.7292 |
| 14 January, 2026 | 28.9793 |
| 13 January, 2026 | 29.0075 |
| 12 January, 2026 | 29.0055 |
| 9 January, 2026 | 29.0753 |
| 8 January, 2026 | 29.4004 |
| 7 January, 2026 | 29.8497 |
| 6 January, 2026 | 29.613 |
| 5 January, 2026 | 29.3082 |
| 2 January, 2026 | 29.3155 |
| 1 January, 2026 | 29.0552 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of LIC MF Healthcare Fund-Regular Plan-Growth?
The latest NAV of LIC MF Healthcare Fund-Regular Plan-Growth is 27.9683 as on 13 February, 2026.
What are YTD (year to date) returns of LIC MF Healthcare Fund-Regular Plan-Growth?
The YTD (year to date) returns of LIC MF Healthcare Fund-Regular Plan-Growth are -3.74% as on 13 February, 2026.
What are 1 year returns of LIC MF Healthcare Fund-Regular Plan-Growth?
The 1 year returns of LIC MF Healthcare Fund-Regular Plan-Growth are -0.11% as on 13 February, 2026.